Vasodilator drugs in the treatment of peripheral arterial insufficiency.
D000328:Adult; D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D000804:Angiotensin II / Q000627:therapeutic use; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005528:Foot / Q000098:blood supply; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006940:Hyperemia / Q000188:drug therapy; D007383:Intermittent Claudication / Q000188:drug therapy; D007511:Ischemia / Q000188:drug therapy; D007556:Isoxsuprine / Q000627:therapeutic use; D007866:Leg / Q000098:blood supply; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply; D013806:Theophylline / Q000627:therapeutic use; D014043:Tolazoline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014665:Vasodilator Agents; D000804:Angiotensin II; D000628:Aminophylline; D008680:Metaraminol; D013806:Theophylline; D014043:Tolazoline; D007556:Isoxsuprine